Tags

Type your tag names separated by a space and hit enter

Periconceptional folic acid supplementation among women attending antenatal clinic in Anhui, China: data from a population-based cohort study.
Midwifery. 2012 Jun; 28(3):291-7.M

Abstract

OBJECTIVES

to examine the rate of periconceptional and optimal folic acid supplementation, and to characterise their patterns and determinants among antenatal women in central China.

DESIGN

data from 4290 women in the Anhui Birth Defects and Child Development Cohort Study recruited between October 2008 and September 2009 were analysed.

SETTING

seven Maternal and Child Health Centres of two cities (Hefei and Maanshan) in Anhui province of central China.

PARTICIPANTS

women initiating prenatal care were included and asked to complete a structured questionnaire regarding folic acid supplementation.

FINDINGS

sixty-eight per cent (2905/4290) of pregnant women reported taking folic acid supplementation periconceptionally (i.e. at some point before or during early pregnancy), and 32.8% (1405/4290) and 65.2% (2797/4290) had taken it before or during early pregnancy, respectively. However, only 16.1% (690/4290) used it optimally (i.e. regularly from four weeks before pregnancy throughout four weeks after pregnancy). Use of periconceptional folic acid was significantly associated with educational level, household income, registered residence, age, gestational age at recruitment, and planning of pregnancy.

CONCLUSION

optimal folic acid supplementation was relatively low.

IMPLICATIONS FOR PRACTICE

further efforts are needed to inform the population and promote the use of folic acid supplementation.

Links

Publisher Full Text
Aggregator Full Text

Authors+Show Affiliations

Xing XY
Anhui Provincial Key Laboratory of Population Health and Aristogenics, Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University, 81 Meishan Road, Hefei 230032, China. xiuya_2000@sina.com
Tao FB
No affiliation info available
Hao JH
No affiliation info available
Huang K
No affiliation info available
Huang ZH
No affiliation info available
Zhu XM
No affiliation info available
Xiao LM
No affiliation info available
Cheng DJ
No affiliation info available
Su PY
No affiliation info available
Zhu P
No affiliation info available
Xu YY
No affiliation info available
Sun Y
No affiliation info available

MeSH

AdultChinaCohort StudiesDietary SupplementsEducational StatusFemaleFolic AcidHealth Knowledge, Attitudes, PracticeHumansNeural Tube DefectsPatient Acceptance of Health CarePreconception CarePregnancyPrenatal CarePrenatal Nutritional Physiological PhenomenaSocial ClassSocioeconomic FactorsSurveys and QuestionnairesVitamin B ComplexWomen's HealthYoung Adult

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

22015219

Citation

Xing, Xiu-Ya, et al. "Periconceptional Folic Acid Supplementation Among Women Attending Antenatal Clinic in Anhui, China: Data From a Population-based Cohort Study." Midwifery, vol. 28, no. 3, 2012, pp. 291-7.
Xing XY, Tao FB, Hao JH, et al. Periconceptional folic acid supplementation among women attending antenatal clinic in Anhui, China: data from a population-based cohort study. Midwifery. 2012;28(3):291-7.
Xing, X. Y., Tao, F. B., Hao, J. H., Huang, K., Huang, Z. H., Zhu, X. M., Xiao, L. M., Cheng, D. J., Su, P. Y., Zhu, P., Xu, Y. Y., & Sun, Y. (2012). Periconceptional folic acid supplementation among women attending antenatal clinic in Anhui, China: data from a population-based cohort study. Midwifery, 28(3), 291-7. https://doi.org/10.1016/j.midw.2011.04.002
Xing XY, et al. Periconceptional Folic Acid Supplementation Among Women Attending Antenatal Clinic in Anhui, China: Data From a Population-based Cohort Study. Midwifery. 2012;28(3):291-7. PubMed PMID: 22015219.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Periconceptional folic acid supplementation among women attending antenatal clinic in Anhui, China: data from a population-based cohort study. AU - Xing,Xiu-Ya, AU - Tao,Fang-Biao, AU - Hao,Jia-Hu, AU - Huang,Kun, AU - Huang,Zhao-Hui, AU - Zhu,Xiao-Ming, AU - Xiao,Li-Min, AU - Cheng,Dai-Juan, AU - Su,Pu-Yu, AU - Zhu,Peng, AU - Xu,Yuan-Yuan, AU - Sun,Ying, Y1 - 2011/10/19/ PY - 2010/07/16/received PY - 2011/04/08/revised PY - 2011/04/11/accepted PY - 2011/10/22/entrez PY - 2011/10/22/pubmed PY - 2012/10/12/medline SP - 291 EP - 7 JF - Midwifery JO - Midwifery VL - 28 IS - 3 N2 - OBJECTIVES: to examine the rate of periconceptional and optimal folic acid supplementation, and to characterise their patterns and determinants among antenatal women in central China. DESIGN: data from 4290 women in the Anhui Birth Defects and Child Development Cohort Study recruited between October 2008 and September 2009 were analysed. SETTING: seven Maternal and Child Health Centres of two cities (Hefei and Maanshan) in Anhui province of central China. PARTICIPANTS: women initiating prenatal care were included and asked to complete a structured questionnaire regarding folic acid supplementation. FINDINGS: sixty-eight per cent (2905/4290) of pregnant women reported taking folic acid supplementation periconceptionally (i.e. at some point before or during early pregnancy), and 32.8% (1405/4290) and 65.2% (2797/4290) had taken it before or during early pregnancy, respectively. However, only 16.1% (690/4290) used it optimally (i.e. regularly from four weeks before pregnancy throughout four weeks after pregnancy). Use of periconceptional folic acid was significantly associated with educational level, household income, registered residence, age, gestational age at recruitment, and planning of pregnancy. CONCLUSION: optimal folic acid supplementation was relatively low. IMPLICATIONS FOR PRACTICE: further efforts are needed to inform the population and promote the use of folic acid supplementation. SN - 1532-3099 UR - https://www.unboundmedicine.com/medline/citation/22015219/Periconceptional_folic_acid_supplementation_among_women_attending_antenatal_clinic_in_Anhui_China:_data_from_a_population_based_cohort_study_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0266-6138(11)00045-3 DB - PRIME DP - Unbound Medicine ER -